Home / Prices / Extracorporeal Shock Wave Therapy (ESWT)

Extracorporeal Shock Wave Therapy (ESWT)

Rehabilitation estimated about CNY 200-500

Disclaimer: This site is a medical service platform; some page content is AI-assisted. Health-related information does not constitute medical advice. If you have any questions, please consult a healthcare professional. See full disclaimer

Description

A non-invasive treatment using acoustic shock waves delivered externally to stimulate healing in musculoskeletal tissues, commonly used for tendinopathies, plantar fasciitis, and non-union fractures.

Main Uses

Primary clinical uses include: (1) Chronic tendinopathies (e.g., plantar fasciitis, lateral epicondylitis, rotator cuff tendinopathy); (2) Delayed/non-union bone fractures; (3) Calcific tendinitis of the shoulder; (4) Chronic pelvic pain syndrome (CP/CPPS); (5) Erectile dysfunction (low-intensity ESWT). It promotes neovascularization, tissue regeneration, anti-inflammatory effects, and pain modulation via mechanotransduction.

Normal Range

Extracorporeal shockwave therapy (ESWT) is not a diagnostic laboratory test with numerical 'values' or reference ranges; it is a non-invasive physical treatment modality. Therefore, there is no 'normal range', 'high value', or 'low value' in the conventional biomedical sense. Treatment parameters (e.g., energy flux density: 0.03–0.60 mJ/mm², pulse frequency: 1–20 Hz, total pulses per session: 1,000–3,000) are protocol-specific and determined by clinical indication, device type (focused vs. radial), and patient tolerance—not standardized biomarkers.

Low Values - Possible Causes

N/A — ESWT does not yield quantitative lab values; 'low' has no clinical meaning in this context. However, subtherapeutic outcomes may result from inadequate energy dosage, insufficient treatment sessions, incorrect anatomical targeting, poor patient selection (e.g., advanced tissue degeneration), or device calibration issues.

High Values - Possible Causes

N/A — ESWT does not produce measurable 'high values'. Adverse effects (e.g., petechiae, transient pain, hematoma) may occur with excessive energy flux density (>0.60 mJ/mm²), excessive pulse count (>3,000/session), overlapping applications, or treatment over contraindicated areas (e.g., lung tissue, major nerves, growth plates, malignancy sites).

extracorporeal shockwave therapy non-invasive musculoskeletal treatment chronic tendinopathy therapy

estimated about CNY 200-500